Pentavalent Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-11-2024
- Paid Up Capital ₹ 1.81 M
as on 15-11-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 15-11-2024
- Revenue 356.01%
(FY 2023)
- Profit 300.13%
(FY 2023)
- Ebitda 190.08%
(FY 2023)
- Net Worth 145.76%
(FY 2023)
- Total Assets 359.35%
(FY 2023)
About Pentavalent Bio Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.81 M.
The company currently has active open charges totaling ₹2.00 Cr.
Murali Harishchandra and Soumya Paul serve as directors at the Company.
- CIN/LLPIN
U85110KA2015PTC078991
- Company No.
078991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pentavalent Bio Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soumya Paul  | Director | 24-Feb-2015 | Current |
| Murali Harishchandra | Director | 04-Dec-2015 | Current |
Financial Performance of Pentavalent Bio Sciences.
Pentavalent Bio Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 356.01% increase. The company also saw a substantial improvement in profitability, with a 300.13% increase in profit. The company's net worth Soared by an impressive increase of 145.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pentavalent Bio Sciences?
In 2023, Pentavalent Bio Sciences had a promoter holding of 94.95% and a public holding of 5.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 01 Dec 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Pentavalent Bio Sciences?
Unlock and access historical data on people associated with Pentavalent Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pentavalent Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pentavalent Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
